These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 5027148

  • 1. Pyridoxine administration in sickle cell disease: an unsuccessful attempt to influence the properties of sickle hemoglobin.
    Beutler E, Paniker NV, West CJ.
    Biochem Med; 1972 Apr; 6(2):139-43. PubMed ID: 5027148
    [No Abstract] [Full Text] [Related]

  • 2. Considerations in the use of B6 vitamers in hematologic disorders: I. Red cell transport and metabolism of pyridoxal.
    Solomon LR.
    Blood; 1982 Mar; 59(3):495-501. PubMed ID: 7059667
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. SIMULTANEOUS RADIOACTIVE TRACER STUDIES OF ERYTHROPOIESIS AND RED-CELL DESTRUCTION IN SICKLE-CELL DISEASE AND SICKLE-CELL HAEMOGLOBIN/THALASSAEMIA.
    MALAMOS B, BELCHER EH, GYFTAKI E, BINOPOULOS D.
    Br J Haematol; 1963 Oct; 9():487-98. PubMed ID: 14076131
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of sickle hemoglobin and desickling agents by falling ball viscometry.
    Paniker NV, Ben-Bassat I, Beutler E.
    J Lab Clin Med; 1972 Aug; 80(2):282-90. PubMed ID: 4339821
    [No Abstract] [Full Text] [Related]

  • 10. Pyridoxal phosphate as an antisickling agent in vitro.
    Kark JA, Tarassoff PG, Bongiovanni R.
    J Clin Invest; 1983 May; 71(5):1224-9. PubMed ID: 6853710
    [Abstract] [Full Text] [Related]

  • 11. Vitamin B 6 requirement of young adult women.
    Donald EA, McBean LD, Simpson MH, Sun MF, Aly HE.
    Am J Clin Nutr; 1971 Sep; 24(9):1028-41. PubMed ID: 5094477
    [No Abstract] [Full Text] [Related]

  • 12. Effect of piracetam on sickle erythrocytes and sickle hemoglobin.
    Asakura T, Ohnishi ST, Adachi K, Ozguc M, Hashimoto K, Devlin MT, Schwartz E.
    Biochim Biophys Acta; 1981 May 29; 668(3):397-405. PubMed ID: 7236716
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Editorial: Delay time of gelation: a possible determinant of clinical severity in sickle cell disease.
    Eaton WA, Hofrichter J, Ross PD.
    Blood; 1976 Apr 29; 47(4):621-7. PubMed ID: 1260125
    [No Abstract] [Full Text] [Related]

  • 16. Dependence of pyridoxine metabolism on riboflavin status in sickle cell patients.
    Adelekan DA, Adekile AD, Thurnham DI.
    Am J Clin Nutr; 1987 Jul 29; 46(1):86-90. PubMed ID: 3604973
    [Abstract] [Full Text] [Related]

  • 17. Cyanate and sickle-cell disease.
    Cerami A, Peterson CM.
    Sci Am; 1975 Apr 29; 232(4):44-50. PubMed ID: 1114310
    [No Abstract] [Full Text] [Related]

  • 18. RED CELL SURVIVAL STUDIES.
    ANDERSON ET, TROBAUGH FE.
    Presbyt St Lukes Hosp Med Bull; 1964 Apr 29; 3():53-9. PubMed ID: 14171444
    [No Abstract] [Full Text] [Related]

  • 19. [Activity of erythrocyte aspartate aminotransferases and its stimulation in vitro with pyridoxal phosphate in children with obesity].
    Piatnitskaia IN, Saprunova MM, Bogdanov NG.
    Pediatriia; 1982 May 29; (5):41-3. PubMed ID: 7099848
    [No Abstract] [Full Text] [Related]

  • 20. Rheological assessment of antisickling effects of pyridoxine and pyridoxal.
    Kuranstin-Mills J, Lessin LS.
    Blood Cells; 1982 May 29; 8(2):315-28. PubMed ID: 7159755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.